The various organs of the body harbor blood vessel networks that display unique structural and functional features; however, the mechanisms that control organ-specific vascular development and physiology remain mostly unknown. In the developing mouse brain, avb8 integrin-mediated TGF-b activation and signaling is essential for normal blood vessel growth and sprouting. Whether integrins activate TGF-b signaling pathways in vascular endothelial cells (ECs), neural cells, or both, has yet to be determined. Here, we have generated and characterized mice in which TGF-b receptors are specifically deleted in neuroepithelial cells via Nestin-Cre, or in ECs via a novel Cre transgenic strain (Alk1 GFPCre ) in which Cre is expressed under control of the endogenous activin receptor-like kinase 1 (Alk1) promoter. We report that deletion of Tgfbr2 in the neuroepithelium does not impact brain vascular development. In contrast, selective deletion of the Tgfbr2 or Alk5 genes in ECs result in embryonic lethality because of brain-specific vascular pathologies, including blood vessel morphogenesis and intracerebral hemorrhage. These data reveal for the first time that avb8 integrin-activated TGF-bs regulate angiogenesis in the developing brain via paracrine signaling to ECs.
The various organs of the body harbor blood vessel networks that display unique structural and functional features; however, the mechanisms that control organ-specific vascular development and physiology remain mostly unknown. In the developing mouse brain, avb8 integrin-mediated TGF-b activation and signaling is essential for normal blood vessel growth and sprouting. Whether integrins activate TGF-b signaling pathways in vascular endothelial cells (ECs), neural cells, or both, has yet to be determined. Here, we have generated and characterized mice in which TGF-b receptors are specifically deleted in neuroepithelial cells via Nestin-Cre, or in ECs via a novel Cre transgenic strain (Alk1 GFPCre ) in which Cre is expressed under control of the endogenous activin receptor-like kinase 1 (Alk1) promoter. We report that deletion of Tgfbr2 in the neuroepithelium does not impact brain vascular development. In contrast, selective deletion of the Tgfbr2 or Alk5 genes in ECs result in embryonic lethality because of brain-specific vascular pathologies, including blood vessel morphogenesis and intracerebral hemorrhage. These data reveal for the first time that avb8 integrin-activated TGF-bs regulate angiogenesis in the developing brain via paracrine signaling to ECs. The elaborate vascular network within the brain develops mainly via angiogenesis, the formation of new blood vessels via endothelial cell (EC) growth and sprouting. 1 Proper regulation of angiogenesis in the brain also involves recruitment of pericytes 2, 3 as well as adhesion and communication with neurons and glia in the local environment. 4 These events are orchestrated by an assortment of growth factors, extracellular matrix (ECM) proteins as well as cell surface receptors and intracellular signaling effectors. 5 Perturbation of various signaling pathways results in abnormal blood vessel morphogenesis and intracerebral hemorrhage. For example, mice genetically null for transcription factors such as inhibitors of differentiation (Id)1/3, 6 Friend leukemia integration 1, 7 or cAMP response element-binding proteinbinding protein 8 develop intracerebral hemorrhage phenotypes. Brain vascular phenotypes have been reported in mice lacking Notch signaling mediators such as presenilin-1 9 and Numb. 10 In addition, canonical Wnt signaling pathways have shown to be essential for normal blood-brain barrier formation and vascular morphogenesis in the embryonic brain. [11] [12] [13] Genetic ablation of the EC-expressed orphan G protein-couple receptor, GPR124/Tem5, also causes brain-specific vascular pathologies likely due to impaired angiogenesis. 14 Integrins, which are heterodimeric receptors comprises a-and b-subunits, have important roles in development of most organs and tissues, including the brain. 15 Many integrins are expressed in neural and vascular cells in the brain; 16 however, avb8 integrin is absolutely essential for neural regulation of vascular development. Mouse embryos genetically null for integrin b8 (Itgb8 À/À ) develop disorganized and distended blood vessels within the ganglionic eminence and display severe intracerebral hemorrhage beginning at embryonic day (E)11.5. 17 Adult Itgb8 À/À mice also display progressive neurological deficits likely due to prior vascular insults. 18 Mice deficient in integrin av (Itgav À/À ) also develop abnormal angiogenesis and intracerebral hemorrhage. 19 Furthermore, selective deletion of av or b8 integrin genes in neuroepithelial cells, but not ECs, causes cerebral hemorrhage phenotypes similar to those that develop in complete knockouts. These data reveal that neuroepithelial cells are the primary cell types in which integrin avb8 functions during brain vascular development. 20 In vitro experiments have shown that avb8 integrin can activate ECM-bound latent TGF-b1 and TGF-b3 by recognizing specific arginine-glycine-aspartic acid (RGD) sequences found within the latent-associated proteins. 21, 22 Recently, it was shown that mice harboring homozygous mutations of the RGD sequence in TGF-b1 combined with homozygous null alleles of TGF-b3 (Tgfb1 RGE/RGE Tgfb3 À/À ) developed embryonic intracerebral hemorrhage phenotypes. 23 Although this TGF-b1/3 double knockout study supports the hypothesis that neural-expressed integrin avb8 mediates TGF-b activation, which in turn controls the properties of neighboring ECs, additional experiments have been necessary for determining whether TGF-b signaling in ECs, neural cells, or both cell types in combination is required for normal angiogenesis in the brain.
TGF-b subfamily signals are transduced by the TGF-b type II receptor (TGFBR2) and the TGF-b type I receptor (TGFBR1; ALK5). TGFBR2 and ALK5 are expressed in numerous cell types and are involved in a variety of cellular processes. [24] [25] [26] [27] There have been previous reports of conditional knockout (cKO) mouse strains in which each receptor has been ablated in ECs using several Cre transgenes; for example, when Tgfbr2 or Alk5 was deleted by Tie1-Cre in which Cre activity begins around E8, 28 Tie1-Cre;Alk5 f/f and Tie1-Cre;Tgfbr2 f/f mice were lethal before E10.5, recapitulating the null phenotypes. 29 In contrast, EC-specific knockouts of Alk5 or Tgfbr2 by the L1Cre transgenic mice, in which Cre is active beginning at E13.5 within ECs of certain organs including the lungs and brain, were viable and did not exhibit any apparent vascular phenotypes. 30 Studies of these TGF-b receptors with Tie2-Cre and Cdh5-CreERT2 showed some brain vascular phenotypes, but these studies were mostly focused on the role of TGF-b receptor signaling in heart development, and did not closely analyze the roles of these receptors in neural cells versus ECs in brain vascular development. [31] [32] [33] In this study, we report the generation of a novel EC-specific Cre (Alk1 GFPCre ), in which Cre is active at appropriate developmental stages to allow analysis of cerebral vascular development. Utilizing the Alk1
GFPCre and NestinCre transgenes, we demonstrate for the first time that the TGF-b receptors have an essential role in ECs, but not in neural cells, for proper regulation of cerebral vascular development.
MATERIALS AND METHODS Mouse Strains and Mating Scheme
Mice were maintained under standard specific-pathogen-free conditions, and all animal procedures performed were reviewed and approved by the University of Florida and University of Texas MD Anderson Cancer Center Institutional Animal Care and Use Committee. Generation of mouse strains (Tgfbr2-floxed, Alk5-floxed, L1Cre, Nestin-Cre, and ROSA26 reporter mice) used in this study was previously described. 30, [34] [35] [36] [37] Mice were on a mixed genetic background of C57BL/6J (B6) and 129SvJ (129). For monitoring the Cre activity, male Alk1
GFPCre mice were crossed with female ROSA26 reporter (R26R) line, and embryos at various developmental stages, neonatal pups, and adult mice were collected for X-gal staining. When female mice had a vaginal plug, the stage of the embryo was judged as at E0.5. For obtaining conditional homozygous mutant embryos, Alk1
GFPCre/þ ;Alk5 f/þ and Alk1 GFPCre/þ ;Tgfbr2 f/þ (or NestinCre;Tgfbr2 f/þ ) males were mated with Alk5 f/f and Tgfbr2 f/f females, respectively.
Isolation of Primary Neonatal Astrocytes
Astrocytes were cultured as previously described. 38 Briefly, neonatal mouse brains (PN1-PN3) were removed from the skull and placed in sterile, ice-cold PBS. Whole neocortices were dissected and the hippocampus was removed to leave only the cortical sheets. The meninges were stripped away, and the cortical sheets were minced with a razorblade and digested for 30 min at 37 1C in DMEM containing 150 units/ ml collagenase (Worthington) and 40 mg/ml deoxyribonuclease (Sigma). The cortical tissue was then triturated in DMEM containing 10% calf serum (Sigma) and filtered through a 50 mm sterile mesh. The resulting single-cell suspension was plated onto T-75 tissue culture flasks that had been pre-coated with 3 mg/ml mouse laminin (Sigma). After 7-10 days, the astroglial cells formed a confluent monolayer with neurons, oligodendrocytes, and fibroblasts growing on top. These contaminating cells were removed by rotary shaking the flasks overnight at 250 rpm.
Analysis of Tgfbr2-Dependent SMAD2/3 Phosphorylation in Astrocytes
To interrogate TGF-b-induced SMAD phosphorylation, astrocytes were grown on laminin-coated glass coverslips in DMEM containing 10% calf serum (Sigma). Cells were serum starved for 16 h and then stimulated with 1 ng/ml TGF-b1 (R&D Systems). Cells were then fixed in 4% PFA/PBS and immunofluorescently labeled with a rabbit polyclonal antibody recognizing total SMAD2/3. Subcellular localization of SMAD2/3 was then visualized with goat anti-rabbit secondary antibodies conjugated to Alexa488 (Molecular Probes). Alternatively, cells were stimulated with TGF-b1 and then lysed in RIPA buffer (10 mM Tris, pH 7.4, 1% NP40, 0.5% deoxycholate, 0.1% SDS, 150 mM NaCl, and 1 mM EDTA). Protein concentrations in detergent-soluble fractions were determined using a BCA assay kit (Thermo Scientific). Lysates (5-10 mg protein per lane) were mixed with 2 Â SDS sample buffer, resolved on 10% polyacrylamide gels and then immunoblotted with an anti-phosphorylated-SMAD2 rabbit polyclonal antibody (Cell Signaling Technologies).
X-Gal Staining
Embryos were collected from pregnant R26R female crossed with Alk1
GFPCre male mice at various embryonic stages such as E9.5, 10.5, 11.5, 12.5, 15.5, and 17.5 embryonic stages and postnatal stage. For the embryos older than E11.5, internal organs such as lung, liver, heart, intestine, eyes, brain, kidney, and sternum were dissected out for whole mount X-gal staining as described previously. 39 Whole mount stained embryos and organs were subjected to paraffin embedding for histological analyses. Histological sections for X-gal stained tissues were counterstained with nuclear fast red.
Histology and Immunohistochemistry
Paraffin-embedded tissues were sectioned in 5-7 mm slices for hematoxylin and eosin or immunohistochemical staining. For EC staining, 1:100 a-PECAM (BioCare, Santa Cruz) using BioCare's Rat on Mouse AP staining kit were used according to the manufacturer's protocol with some modifications. Briefly, after dehydration the sections were treated with 3% H 2 O 2 for 10 min, washed with 1 Â Tris-buffered saline then treated with trypsin (BioCare, Santa Cruz) mix for 7 min at 37 1C. The sections were incubated in the primary antibody overnight at 4 1C. The alkaline phosphotase reaction was carried out using BioCare's Vulcan Fast Red Staining kit. For staining of smooth muscle layers, 1:800 a-SMA (Sigma) was carried out using VectaStains's MouseOn-Mouse kit according to the manufacturer's protocol. Vector DAB staining kit (Vector Laboratory) was used to visualize HRP reaction. All immunostained sections were counterstained with hematoxylin.
Generation and Analysis of Alk1
GFPCre Mice An Alk1-eGFPCre-knock-in (Alk1 GFPCre -KI) vector was constructed as following. SV40 splice donor and acceptor signals (SD/SA), internal ribosomal entry sequence (IRES) and poly(A) signal (pA) were sequentially subcloned into pBluescriptIISK( þ ), of which XhoI site was deleted, and the eGFPCre fusion gene was subcloned between IRES and pA. This SD/SA-IRES-eGFPCre-pA fragment was replaced with SD/SA-IRES-LacZ fragment in the Alk1-SIBN2 knock-in vector previously generated. 39 After electroporation of the linearlized knock-in vector, 365 G418 and FIAU-resistant clones were screened by Southern hybridization analysis by digesting genomic DNA with EcoRI followed by hybridization with a [ ) develop cerebral hemorrhage phenotypes, 23 similar to those phenotypes reported in av and b8 integrin-deficient mice. 20, 40 In order to address whether vascular pathologies of the central nervous system (CNS) in Tgfb1 RGE/RGE Tgfb3 À/À mice were due to the defects in TGF-b receptor signaling in neural cells we selectively ablated TGF-b receptors in the NE using Nestin-Cre transgenic mice in which the Cre recombinase is expressed in CNS neural progenitor cells beginning at approximately E10. 37, 41, 42 We analyzed control (Nestin-Cre( þ );Tgfbr2 f/þ or Nestin-Cre(À);Tgfbr2 f/f ) and mutant (Nestin-Cre( þ ); Tgfbr2 f/f ) embryos, and found that the mutant mice did not display CNS vascular defects at E12.5 ( Figures 1a  and b) , a stage when intracerebral hemorrhage was evident in Nestin-Cre( þ );Itgav f/À cKOs (Figure 1c ). Nestin-Cre( þ );Tgfbr2 f/f cKOs were born in the expected Mendelian ratios. Of 231 neonatal animals analyzed, 55 mice (23%) were Nestin-Cre( þ );Tfgbr2 f/f . Analysis of postnatal life span in control (n ¼ 15) and mutant (n ¼ 13) littermates revealed that conditional Tgfbr2 knockouts survived for up to 2 years without developing obvious phenotypes. cKO mice did not display neurological deficits resulting from long-term or acute neurovascular abnormalities or blood-brain barrier disruption. Analysis of neurovascular unit and blood-brain barrier integrity by immunostaining fixed brain sections with anti-mouse IgG and anti-transferrin did not reveal pathological extravasation of these endogenous circulating proteins into the brain parenchyma of Tgfbr2-control of cKO mice (data not shown). These data reveal that ablation of TGF-b receptor signaling in neural cells of the brain does not significantly impact neurovascular development or physiology.
Cre-mediated recombination of the Tgfbr2-flox allele was confirmed by PCR-based analysis of genomic DNA isolated from astrocytes cultured from Nestin-Cre( þ );Tgfbr2 f/þ newborn mice (Figure 1d ). Loss of TGFBR2 signaling was verified in primary astrocytes. We stimulated control and mutant primary astrocytes with TGF-b1 (1 ng/ml), prepared detergent-soluble cell lysates, and immunoblotted resolved proteins with anti-pSMAD2 antibodies. As shown in Figure 1e , we detected a TGF-b1-dependent increase in SMAD2 phosphorylation in control cells, whereas there was no increase in SMAD2 phosphorylation levels in Tgfbr2 mutant astrocytes. These data demonstrate that signaling mediated by TGFBR2 in the embryonic CNS NE is not essential for cerebral vascular development. In addition, TGF-b1 stimulation of control cells resulted in SMAD2/3 translocation from the cytoplasm to the nucleus ( Figure 1f) ; in contrast, mutant cells did not show nuclear translocation of SMAD2/3 (Figure 1g ).
Generation and Characterization of Alk1
GFPCre -Knockin Mouse Strain as a Novel EC-Specific Cre Transgene In order to investigate whether TGF-b signaling in ECs has an essential role in cerebral vascular development, we utilized a novel EC-specific Cre deleter line. The Alk1-eGFPCre-knockin (Alk1 GFPCre ) mouse line was generated by inserting the eGFPCre fusion gene into the endogenous Alk1 (activin receptor-like kinase 1) locus via homologous recombination (Supplementary Figure 1) . This strategy allows for expression of the eGFPCre fusion protein in cells where endogenous Alk1 gene products are normally expressed. The detailed information for vector construction and targeting scheme is described in Materials and methods section (Supplementary Figure 1) . Cre activity during development was monitored by analyzing the X-gal staining pattern of Alk1
GFPCre/þ R26R mice. Littermates of Alk1 GFPCre/þ R26R and Alk1 þ /þ ;R26R were used as a control for endogenous lacZ activity at all stages. Consistent to our previous data from Alk1 lacZ and Tg(Alk1-lacZ) mice, 39, 43 the Cre activity was primarily detected in endothelium of developing blood vessels of Alk1 GFPCre R26R embryos throughout development. X-gal-positive cells were detected in the vascular tree of E9.5 embryos with patchy and spotty staining patterns (Figure 2a) , and they were detected in more uniform patterns within the vasculature as development progressed (Figures 2b-d) . Histological sections of whole mount stained E11.5 embryos demonstrated that the X-gal-positive cells were vascular ECs within large and small vessels surrounding and invading the NE of the embryonic brain (Figure 2e ). In the heart, X-gal was found in endocardial cells and mesenchymal cells of the atrioventicular (AV) cushion ( Figure 2f ). As endogenous Alk1 is not expressed in the AV cushion cells, 39 this data indicate that Cre-medicated recombination has occurred in endocardial cells before the endocardium-mesenchymal transition in the artrioventricular region. X-gal-positive cells were also present in the blood vessels in the brain (Figures 2g and h) . Strong lacZ expression/activity was detected in the vasculature of most organs during developmental and neonatal stages (Figures 2i-l) . In the lungs, vascular ECs were X-gal-positive while the airway epithelial cells and smooth muscle layers of the airways and blood vessels were negative (Figure 2j ). The vessels in the glomeruli of developing and neonatal kidney showed X-gal-positive (Figures 2k and l) .
Endothelial-Specific Deletion of Tgfbr2 or Alk5
Results in Intracerebral Hemorrhage When Tgfbr2 or Alk5 was selectively deleted by Alk1
GFPCre mice, no Alk1
GFPCre/þ Tgfbr2 f/f and Alk1 GFPCre/þ Alk5 f/f pups were recovered at birth, indicating these mutant mice were embryonic lethal. Timed mating studies revealed that these mutant mice begin to show obvious phenotypes at E11.5 and died at around E13.5-E15.5 (Table 1) .
At E10.5, neither Alk1
Alk5 f/f embryos exhibited any noticeable phenotypes and were indistinguishable from control littermates (data not shown). At E11.5, however, 100% of mutant embryos exhibited bilateral hemorrhage in forebrain regions (Figures 3a, b and f; Table 1 ). Intracerebral hemorrhages were progressively more severe in mutant embryos at advanced developmental stages (Figures 3c-e, g and h) . The hemorrhage was largely confined to areas of the forebrain (Figures 3c and d) , but in some E13.5 and E14.5 embryos hemorrhage was detected in the developing midbrain, hindbrain, and spinal cord (Supplementary Figure 2 ; Table 1 ). It is important to note that these mutants did not exhibit obvious hemorrhage in organs other than the brain and spinal cord. Although the phenotypes of Tgfbr2 and Alk5 mutants are remarkably similar to each other, Alk5 mutants died at approximately E13.5, 1 day earlier than Tgfbr2 mutants that died at around E14.5 (Table 1 ). E13.5 Alk5 mutants showed abnormalities in heart development: pericardial cavity was enlarged and the heart appeared to be underdeveloped (Figure 3d ).
Blood Vessels Fail to Invade into the Neuroepithelial Layers in Tgfbr2 and Alk5 Mutants
During development blood vessels in the perineural vascular plexus invade the NE by migrating along neuroepithelial and radial glial cell processes. Histological sections of the Tgfbr2-and Alk5-conditional knockout (cKO) mutant embryos revealed that TGF-b signaling in ECs is necessary for these processes. At E11.5, regularly spaced blood vessels are apparent in the NE layer of control embryos (Figures 4a  and b) . In both Alk5-and Tgfbr2-cKO mutants, patterns of blood vessel sprouting were abnormal. At E11.5, glomeruloid-like aggregates of CD31-positive microvessels were found within the NE (Figures 4d and f) and these pathologies were even more apparent E12.5 ( Supplementary Figures 3g  and h ). In addition, at E11.5 cavitations had formed in the ventricular zone of mutant animals ( Figure 4f ). Interestingly, in the mutants no apparent abnormalities in blood vessel architecture outside of the NE, for example, in the perineural vascular plexus, were observed, indicating that TGF-b signaling in ECs has an essential role for the invasion into the NE. Along these lines, angiogenesis in the other organs such as lung and peripheral tissues was also unaffected in the Tgfbr2-and Alk5-cKO mutants (Supplementary Figure 4 ; Figure 5 ). As shown in Figure 3d , Alk5-cKO mutants showed defective heart development. Previously, it was shown that atrioventricular (AV) cushions of Tie2-Cre;Alk5 f/f mice were hypoplastic. 32 Histological analysis revealed that Alk5-cKO heart may have a defect in completion of turning, which results in delayed development of the right ventricle. Abnormal positioning of AV cushion and impaired closure of ventricular septum were found most consistently in the Alk5-cKO mutants (Figures 5d and f) , but no apparent hypoplasia of AV cushions was observed. These differences are likely due to differences in the temporal expression of Cre during heart development between Tie2-Cre and Alk1
GFPCre lines.
DISCUSSION
Here, we have used gene knockout strategies in mice to determine cell type-specific roles for TGF-b receptors in brain vascular development. We show that genetic ablation of Tgfbr2 in CNS neuroepithelial cells does not result in obvious vascular pathologies (Figure 1 ). In contrast, ablation of Tgfbr2 or Alk5 in ECs leads to abnormal cerebral blood vessel morphogenesis and intracerebral hemorrhage (Figures 3 and  4) . These data are the first in vivo evidence demonstrating that TGF-b signaling in ECs, but not in neural cells, is required for normal angiogenesis and blood-brain barrier development during embryogenesis. Prior reports have shown that both TGF-b1 and TGF-b3 are required for normal regulation of brain vascular development. 23 Furthermore, the neuroepithelial cell-expressed integrin avb8 has been shown to be a major activator of TGFb signaling in the developing brain. 20, 40 However, it remained uncertain whether autocrine or paracrine TGF-b signaling pathways were involved in these processes. The data we report herein provide direct in vivo evidence to support a model in which a paracrine signaling axis-comprises avb8 integrin in neuroepithelial cells, 17, 20 latent TGF-b1 and b3 in vascular basement membranes and canonical TGF-b receptors in vascular ECs-is essential for normal angiogenesis and vascular barrier formation in the embryonic brain.
Numerous knockout mouse models exhibit intracerebral hemorrhage phenotype without apparent defects in vascular beds within other organs, suggesting that brain vascular development is regulated via specific signaling pathways. Our study demonstrates that TGF-b signaling via TGFBR2 and ALK5 in ECs is one such important pathway. Our study also shows that TGF-b signaling in ECs is crucial during specific developmental stages. Genetic ablation of Tgfbr2 or Alk5 using Tie1-Cre leads to yolk sac vascular pathologies at E9.5 and lethality by E11. 44 In the Alk1 GFPCre strain used in this study, Cre expression occurs approximately 1-2 days later than the other commonly used Tie1-Cre and Tie2-Cre transgenic strains. Owing to the temporal difference in Cre 
activation, the Alk1
GFPCre mice allows for Alk5-and Tgfbr2-cKO embryos survival to E14.5 and beyond, thus revealing the importance of TGF-b signaling in ECs of the brain vasculature. In contrast, cerebral vascular development was unaffected when Tgfbr2 or Alk5 was deleted in ECs with the L1Cre line, which begins to express Cre in brain ECs after E13.5. 30 These results indicate that TGF-b signaling in ECs, likely initiated via avb8 integrin in perivascular neuroepithelial cells, is crucial for active stages of angiogenesis, but may be dispensable for the maintenance of a more established brain vasculature.
Angiogenesis involves both EC proliferation and directional sprouting, with specialized endothelial tip cells having important roles in directional navigation by interpreting extracellular cues within the tissue microenvironment. We propose that TGF-b receptors in brain endothelial tip cells may serve vital roles in sensing integrin-activated TGF-b1 and TGF-b3 within the neural environment. Various other transmembrane proteins, such as the VEGF receptors Neuropilin 1 and VEGFR2, as well as Notch/Delta family members are expressed in tip cells where they have essential roles in blood vessel sprouting. 45 It will be interesting to determine whether TGF-b signaling is integrated with these other pathways and how these various ligand-receptor pairs coordinately control angiogenesis and barrier functions in the brain. TGF-bs modulate intracellular signaling via SMADdependent (canonical) and SMAD-independent (noncanonical) pathways. 46 Recent data reveal that cell polarity and directional migration are regulated by TGF-b receptor signaling through components of the Par complex, comprised of Cdc42, Par6, and aPKCz. 47 Hence, it is enticing to speculate that TGF-b-mediated activation of the Par complex, possible in combination with SMAD activation, is necessary for directional navigation of blood vessels as they invade through the brain microenvironment. It remains uncertain whether there is a differential requirement for canonical versus non-canonical TGF-b signaling in angiogenesis in the developing brain; however, the Alk1 GFPCre transgenic strain we describe herein will enable us to decipher the exact TGF-b signaling pathways within ECs that are necessary for angiogenesis within the developing brain. The orphan G protein-coupled receptor, GPR124/Tem5, regulates EC directional migration via a Cdc42-dependent pathway, and genetic ablation of GPR124 in ECs leads to brain-specific vascular pathologies. 14, 48 Hence, TGF-b receptors may function in coordination with GPR124 to regulate the Par complex during EC growth and sprouting in the developing brain.
